| Name | Campbell's Pharmacy |
|---|---|
| Organization Name | 140 Main Street Corporation |
| Location | 2175 Highway 35, Sea Girt, New Jersey 08750 |
| Type | Long Term Care Pharmacy |
| Phone | (732) 974-2929 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.
With antibiotic-resistant infections increasingly common, and a dangerous lack of new infection fighters in the drug development pipeline, it's more important than ever to use existing antibiotics appropriately. This week, infectious disease experts are helping to educate consumers, health care providers, and policymakers about when antibiotics can help, when misuse of these lifesaving drugs can do more harm than good, and the tremendous need for new antibiotics to protect patients.
Some Americans who froze their credit reports following the big data breach this year at the credit-rating firm Equifax may be in for a surprise if they try to purchase insurance on the federal health law's marketplaces. That freeze could trigger a delay in the application process.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.
› Verified 5 days ago
| NPI Number | 1316720790 |
| Organization Name | 140 MAIN STREET CORPORATION |
| Doing Business As | CAMPBELL'S PHARMACY |
| Type | Long Term Care Pharmacy |
| Address | 2175 Highway 35, Sea Girt, NJ 08750 |
| Phone Number | 732-974-2929 |
News Archive
Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.
With antibiotic-resistant infections increasingly common, and a dangerous lack of new infection fighters in the drug development pipeline, it's more important than ever to use existing antibiotics appropriately. This week, infectious disease experts are helping to educate consumers, health care providers, and policymakers about when antibiotics can help, when misuse of these lifesaving drugs can do more harm than good, and the tremendous need for new antibiotics to protect patients.
Some Americans who froze their credit reports following the big data breach this year at the credit-rating firm Equifax may be in for a surprise if they try to purchase insurance on the federal health law's marketplaces. That freeze could trigger a delay in the application process.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.
› Verified 5 days ago
| NPI Number | 1679670509 |
| Organization Name | 140 MAIN STREET CORPORATION |
| Doing Business As | CAMPBELL'S PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 2175 Highway 35, Sea Girt, NJ 08750 |
| Phone Number | 732-974-2929 |
News Archive
Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.
With antibiotic-resistant infections increasingly common, and a dangerous lack of new infection fighters in the drug development pipeline, it's more important than ever to use existing antibiotics appropriately. This week, infectious disease experts are helping to educate consumers, health care providers, and policymakers about when antibiotics can help, when misuse of these lifesaving drugs can do more harm than good, and the tremendous need for new antibiotics to protect patients.
Some Americans who froze their credit reports following the big data breach this year at the credit-rating firm Equifax may be in for a surprise if they try to purchase insurance on the federal health law's marketplaces. That freeze could trigger a delay in the application process.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.
› Verified 5 days ago
News Archive
Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.
With antibiotic-resistant infections increasingly common, and a dangerous lack of new infection fighters in the drug development pipeline, it's more important than ever to use existing antibiotics appropriately. This week, infectious disease experts are helping to educate consumers, health care providers, and policymakers about when antibiotics can help, when misuse of these lifesaving drugs can do more harm than good, and the tremendous need for new antibiotics to protect patients.
Some Americans who froze their credit reports following the big data breach this year at the credit-rating firm Equifax may be in for a surprise if they try to purchase insurance on the federal health law's marketplaces. That freeze could trigger a delay in the application process.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.
› Verified 5 days ago
Campbell's Pharmacy Type: Long Term Care Pharmacy Location: 2175 Highway 35, Sea Girt, New Jersey 08750 Phone: (732) 974-2929 |